These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26200329)
1. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Blitzer A; Brin MF; Stewart CF Laryngoscope; 2015 Aug; 125(8):1751-7. PubMed ID: 26200329 [No Abstract] [Full Text] [Related]
2. Botulinum toxins. Introduction. Klein AW Semin Cutan Med Surg; 2001 Jun; 20(2):69-70. PubMed ID: 11474746 [No Abstract] [Full Text] [Related]
3. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients. van Esch BF; Wegner I; Stegeman I; Grolman W Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079 [TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia. Mor N; Tang C; Blitzer A Otolaryngol Head Neck Surg; 2016 Sep; 155(3):458-61. PubMed ID: 27143711 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Blitzer A; Brin MF; Stewart CF Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279 [TBL] [Abstract][Full Text] [Related]
7. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia. Lerner MZ; Lerner BA; Patel AA; Blitzer A Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and therapeutic difficulties in laryngeal dystonia]. Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622 [TBL] [Abstract][Full Text] [Related]
9. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study. Mendelsohn AH; Berke GS Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926 [TBL] [Abstract][Full Text] [Related]
10. History of the cosmetic use of Botulinum A exotoxin. Carruthers A; Carruthers J Dermatol Surg; 1998 Nov; 24(11):1168-70. PubMed ID: 9834733 [No Abstract] [Full Text] [Related]
12. Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population. Nerurkar NK; Banu TP J Laryngol Otol; 2014 Jul; 128(7):649-53. PubMed ID: 24999662 [TBL] [Abstract][Full Text] [Related]
13. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues. Young DL; Halstead LA J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039 [TBL] [Abstract][Full Text] [Related]
14. Factors influencing long-term treatment response to botulinum toxin injection for spasmodic dysphonia. Kang MS; Lee SJ; Choi HS; Lim JY Clin Otolaryngol; 2021 Mar; 46(2):436-444. PubMed ID: 33260261 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A: history and current cosmetic use in the upper face. Carruthers A Dis Mon; 2002 May; 48(5):299-322. PubMed ID: 12195262 [TBL] [Abstract][Full Text] [Related]
16. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. Boutsen F; Cannito MP; Taylor M; Bender B J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000 [TBL] [Abstract][Full Text] [Related]
17. A survey of current practices of physicians who treat adductor spasmodic dysphonia in the U.S. Chang CY; Chabot P; Walz CM Ear Nose Throat J; 2009 May; 88(5):E18. PubMed ID: 19444777 [TBL] [Abstract][Full Text] [Related]
18. The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients. Patel AB; Bansberg SF; Adler CH; Lott DG; Crujido L Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):859-63. PubMed ID: 26024910 [TBL] [Abstract][Full Text] [Related]
19. Common practices in botulinum toxin injection for spasmodic dysphonia treatment: A national survey. Shoffel-Havakuk H; Rosow DE; Lava CX; Hapner ER; Johns MM Laryngoscope; 2019 Jul; 129(7):1650-1656. PubMed ID: 30582627 [TBL] [Abstract][Full Text] [Related]
20. Retropharyngeal hematoma following botulinum toxin injection for abductor spasmodic dysphonia. Koh J; Raghav S; Baxter M Ear Nose Throat J; 2017 Dec; 96(12):E45-E46. PubMed ID: 29236283 [No Abstract] [Full Text] [Related] [Next] [New Search]